Recherche
-
Dual Inhibition of FLT3 and AXL by Gilteritinib Overcomes Hematopoietic Niche-Driven Resistance Mechanisms in -ITD Acute Myeloid Leukemia.
(Clinical Cancer Research, 2021-08-16)Article de revue -
JAK2 V617F polycythemia vera and essential thrombocythemia: dynamic clinical features associated with long-term outcomes.
(Blood Cancer Journal. vol. 12, n° 4, pp. 56, 2022-04-08)Article de revueLibre accès -
The presence of a chromosomal abnormality in cytopenia without dysplasia identifies a category of high-risk clonal cytopenia of unknown significance.
(Genes, Chromosomes & Cancer. vol. 62, n° 3, pp. 139-151, 2023-03-01)Article de revue -
Platelets and neutrophils cooperate to induce increased neutrophil extracellular trap formation in JAK2V617F myeloproliferative neoplasms.
(Journal of Thrombosis and Haemostasis, 2023-09-09)Article de revue -
Platelet function studies in myeloproliferative neoplasms patients with Calreticulin or JAK2V617F mutation
(Research and Practice in Thrombosis and Haemostasis. vol. Vol. 7, n° Issue 2, pp. 100060, 2023-02)Article de revueLibre accès -
Assessment of circulating blood lymphocytes in adult patients on rituximab to treat immune thrombocytopenia: Circulating number of NK cells is associated with the response at 6 months.
(British Journal of Haematology, 2023-04-20)Article de revueLibre accès -
CALR-mutated patients with low allele burden represent a specific subtype of essential thrombocythemia: A study on behalf of FIM and GBMHM.
(American Journal of Hematology, 2024-02-25)Article de revueLibre accès -
Role of red cell mass evaluation in myeloproliferative neoplasms with splanchnic vein thrombosis and normal hemoglobin value: a study of the France Intergroupe des Syndromes myeloprolifératifs.
(Haematologica, 2024-02-08)Article de revueLibre accès